Axsome Therapeutics (AXSM) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Axsome Therapeutics (AXSM) is Neutral.

The composite score behind that read is +0.00, weighing +0.23 of bullish evidence against -0.28 bearish.

Axsome Therapeutics last closed at $168.35, -1.02% on the session.

Against the IVW growth benchmark the position is -1.82% over the forecast window.

The read is built from 15 underlying insights — 7 bullish and 8 bearish.

Agreement across those insights is 53%.

Axsome Therapeutics has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Axsome Therapeutics in the 4th percentile on return on equity, where 100 is best.

Axsome Therapeutics is classified under Health Care / Pharmaceuticals, with a market capitalisation of $8.91B.

StockMap tracks Axsome Therapeutics as the 20th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite Axsome Therapeutics ranks 55th of 151 in the group, against a group median of -0.08.